TrialEuropean journal of cancer (Oxford, England : 1990)2018

The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer.

Eric Van Cutsem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.